Conyers provided Cayman Islands and British Virgin Islands legal advice to OrbusNeich Medical Group Holdings Limited (“OrbusNeich Medical”) in connection with its US$61.6 million (approximately HK$481 million) global offering of 54,633,000 shares on the Main Board of The Stock Exchange of Hong Kong (Stock Code: 6929).

Headquartered in Hong Kong, OrbusNeich Medical mainly develop and manufacture PCI/PTA balloons to sell to over 70 countries and regions worldwide. OrbusNeich Medical are actively expanding into neuro vascular intervention and structural heart disease areas other than specialising in coronary stent products.

Partner Wynne Lau, Associate Ryan McConvey and Paralegal Adam Ng of Conyers’ Hong Kong office advised on the matter, working alongside the Company’s HK legal advisor, O’Melveny & Myers.

Stay current with our latest legal insights and subscribe today